LINEX

Medicinal product

(Invented) name

LINEX

Active substance (s)

Lactobacillus acidophilus (sp. L.gasseri), Bifidobacterium infantis, Enterococcus faecium

Strength

>=1,2x10(7) KSV

Pharmaceutical form

kietosios kapsulės

Route (s) of administration

vartoti per burną

Legal status for supply

Nereceptinis

Narrow therapeutic index (NTI)

ATC code (s)

A07FA51, Lactic acid producing organisms, combinations

Marketing authorisation holder

Sandoz d.d., Slovėnija

Date of authorisation

1995-02-15

Date of renewal

2007-10-15

Documents

Stage

Perregistruotas

Controlled?

Controlled substance type

Legal basis

10a

Procedure number

Marketing authorisation procedure

Nacionalinė procedūra

Qualitative and quantitative composition

Kapsulėje yra	1 vnt.
Lactobacillus acidophilus (sp. L.gasseri), Bifidobacterium infantis, Enterococcus faecium	>=1,2x10(7) KSV

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
955	6814	1006814	lizdinė plokštelė	N16	Nereceptinis	LT/1/95/0852/001	Tiekiama	-	-	No	-	-	Download
24259	26923	1026923	buteliukas	N16	Nereceptinis	LT/1/95/0852/002	Netiekiama	-	-	No	-	-	Download
111041	97152	1097152	lizdinė plokštelė	N32	Nereceptinis	LT/1/95/0852/003	Tiekiama	2025-01-22	-	No	-	-	Download

Stadijos

Data	Stadija
2007-10-15	Perregistruotas
1995-02-15	Registruotas